Enhanced renal sensitivity of the spontaneously hypertensive rat to urotensin II

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 4, 2008, Pages

  Abdel Razik, Alaa E S ^a   Balment, Richard J ^a   Ashton, Nick ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Glomerular filtration rate; Kidney; Sodium; UT receptor

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE RECEPTOR; URANTIDE; UROTENSIN II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURESIS; EXPERIMENTAL MODEL; GLOMERULUS FILTRATION RATE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY MEDULLA; MALE; MICTURITION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM EXCRETION; SODIUM RETENTION; SODIUM URINE LEVEL; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; WISTAR KYOTO RAT;

EID: 57049104060     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90374.2008     Document Type: Article

References (36)

1. Abdel-Razik AE, Forty EJ, Balment RJ, Ashton N. Renal hemodynamic and tubular actions of urotensin II in the rat. J Endocrinol 198: 617-624, 2008.
2. Ames RS, Sarau HM, Chambers JK, Willette RN, Alyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, McNulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401: 282-286, 1999.
3. Bern HA, Pearson D, Larson BA, Nishioka RS. Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes. Recent Prog Horm Res 41: 533-552, 1985.
4. Bohm F, Pernow J. Urotensin II evokes potent vasoconstriction in humans in vivo. Br J Pharmacol 135: 25-27, 2002.
5. Camarda V, Song W, Marzola E, Spagnol M, Guerrini R, Salvadori S, Regoli D, Thompson JP, Rowbotham DJ, Behm DJ, Douglas SA, Calo G, Lambert DG. Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors. Eur J Pharmacol 498: 83-86, 2004.
6. Charles CJ, Rademaker MT, Richards AM, Yandle TG. Urotensin II: evidence for cardiac, hepatic and renal production. Peptides 26: 2211-2214, 2005.
7. Cheung BM, Leung R, Man YB, Wong LY. Plasma concentration of urotensin II is raised in hypertension. J Hypertens 22: 1341-1344, 2004.
8. Coulouarn Y, Jegou S, Tostivint H, Vaudry H, Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457: 28-32, 1999.
9. Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, Vaudry H. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95: 15803-15808, 1998.
10. Disa J, Floyd LE, Edwards RM, Douglas SA, Aiyar NV. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography. Peptides 27: 1532-1537, 2006.
11. Douglas SA, Ohlstein EH. Urotensin receptors. In: The IUPHAR Compendium of Receptor Characterization and Classification, edited by Girdlestone D. London: IUPHAR Media, 2000, p. 365-372.
12. Dworkin LD, Brenner BM. The renal circulations. In: The Kidney (5th ed.), edited by Brenner BM. Philadelphia: W. B. Saunders, 1996, p. 247-285.
13. Gartlon J, Parker F, Harrison DC, Douglas SA, Ashmeade TE, Riley GJ, Hughes ZA, Taylor SG, Munton RP, Hagan JJ, Hunter JA, Jones DN. Central effects of urotensin-II following ICV administration in rats. Psychopharmacology 155: 426-433, 2001.
14. Gendron G, Gobeil F Jr, Belanger S, Gagnon S, Regoli D, D'Orleans-Juste P. Urotensin II-induced hypotensive responses in Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats. Peptides 26: 1468-1474, 2005.
15. Heller J, Schepke M, Neef M, Woitas R, Rabe C, Sauerbruch T. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension. J Hepatol 37: 767-772, 2002.
16. Lim M, Honisett S, Sparkes CD, Komesaroff P, Kompa A, Krum H. Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure. Circulation 109: 1212-1214, 2004.
17. Lin Y, Tsuchihashi T, Matsumura K, Fukuhara M, Ohya Y, Fujii K, Iida M. Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertens Res 26: 839-845, 2003.
18. Liu Q, Pong SS, Zeng Z, Zhang Q, Howard AD, Williams DL, Davidoff M, Wang R, Austin CP, McDonald TP, Bai C, George SR, Evans JF, Caskey CT. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266: 174-178, 1999.
19. -ΔΔCT method. Methods 25: 402-408, 2001.
20. Maguire JJ, Kuc RE, Davenport AP. Orphan receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131: 441-446, 2000.
21. Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N, Hirata Y. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 19: 2185-2190, 2001.
22. Ng LL, Loke I, O'Brien RJ, Squire IB, Davies JE. Plasma urotensin in human systolic heart failure. Circulation 106: 2877-2880, 2002.
23. Nothacker HP, Wang Z, McNeill AM, Saito Y, Merten S, O'Dowd B, Duckles SP, Civelli O. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1: 383-385, 1999.
24. Ovcharenko E, Abassi Z, Rubinstein I, Kaballa A, Hoffman A, Winaver J. Renal effects of human urotensin-II in rats with experimental congestive heart failure. Nephrol Dial Transplant 21: 1205-1211, 2006.
25. Patacchini R, Santicioli P, Giuliani S, Grieco P, Novellino E, Rovero P, Maggi CA. Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta. Br J Pharmacol 140: 1155-1158, 2003.
26. Proulx CD, Holleran BJ, Lavigne P, Escher E, Guillemette G, Leduc R. Biological properties and functional determinants of the urotensin II receptor. Peptides 29: 691-699, 2008.
27. Russell FD, Meyers D, Galbraith AJ, Bett N, Toth I, Kearns P, Molenaar P. Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol Heart Circ Physiol 285: H1576-H1581, 2003.
28. Shi Y, Cao YX, Lu N, Yao T, Zhu YC. Hemodynamic-independent anti-natriuretic effect of urotensin II in spontaneously hypertensive rats. Peptides 29: 783-794, 2008.
29. Sondermeijer B, Kompa A, Komesaroff P, Krum H. Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension. Am J Hypertens 18: 1195-1199, 2005.
30. Song W, Abdel-Razik AE, Lu W, Ao Z, Johns DG, Douglas SA, Balment RJ, Ashton N. Urotensin II and renal function in the rat. Kidney Int 69: 1360-1368, 2006.
31. Thompson JP, Watt P, Sanghavi S, Strupish JW, Lambert DG. A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study. Anesth Analg 97: 1501-1503, 2003.
32. Totsune K, Takahashi K, Arihara Z, Sone M, Murakami O, Ito S, Kikuya M, Ohkubo T, Hashimoto J, Imai Y. Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy. Peptides 25: 1809-1814, 2004.
33. Wilkinson IB, Affolter JT, de Haas SL, Pellegrini MP, Boyd J, Winter MJ, Balment RJ, Webb DJ. High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man. Cardiovasc Res 53: 341-347, 2002.
34. Winter MJ, Hubbard PC, McCrohan CR, Balment RJ. A homologous radioimmunoassay for the measurement of urotensin II in the euryhaline flounder, Platichthys flesus. Gen Comp Endocrinol 114: 249-256, 1999.
35. Yi L, Gu YH, Wang XL, An LZ, Xie XD, Shao W, Ma LY, Fang JR, An YD, Wang F, Zhang DL. Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China. J Int Med Res 34: 272-283, 2006.
36. Zhang AY, Chen YF, Zhang DX, Yi FX, Qi J, Andrade-Gordon P, de Garavilla L, Li PL, Zou AP. Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. Am J Physiol Renal Physiol 285: F792-F798, 2003.